Valera's Merger

Valera raised a round of funding on September 14, 2017. Investors include Moderna Therapeutics.

Valera, the second venture company formed by Moderna, is focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of infectious diseases. Valera is leveragi…

Articles about Valera's Merger: